| 000 | 01337 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516072633.0 | ||
| 264 | 0 | _c20120404 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1538-2990 | ||
| 024 | 7 |
_a10.1097/MAJ.0b013e3182429866 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFleagle, Jessica M | |
| 245 | 0 | 0 |
_aIron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab. _h[electronic resource] |
| 260 |
_bThe American journal of the medical sciences _cMar 2012 |
||
| 300 |
_a249-51 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAnemia, Iron-Deficiency _xetiology |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTelangiectasia, Hereditary Hemorrhagic _xcomplications |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 700 | 1 | _aBobba, Ravi K | |
| 700 | 1 | _aKardinal, Carl G | |
| 700 | 1 | _aFreter, Carl E | |
| 773 | 0 |
_tThe American journal of the medical sciences _gvol. 343 _gno. 3 _gp. 249-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MAJ.0b013e3182429866 _zAvailable from publisher's website |
| 999 |
_c21444755 _d21444755 |
||